HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Barbui Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

3/2009High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
12/2001CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Barbui Research Topics

Disease

9Thrombosis (Thrombus)
08/2013 - 09/2000
8Neoplasms (Cancer)
10/2016 - 09/2000
7Primary Myelofibrosis (Myelosclerosis)
01/2017 - 01/2000
5Leukemia
10/2013 - 01/2000
4Essential Thrombocythemia
10/2014 - 03/2001
3Splenomegaly
01/2017 - 01/2000
3Hemorrhage
04/2012 - 12/2001
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2001 - 01/2000
2Pruritus (Itching)
01/2017 - 01/2000
2Polycythemia Vera
07/2012 - 04/2008
2Leukocytosis (Pleocytosis)
04/2012 - 08/2008
2Thrombocytosis (Thrombocythemia)
04/2012 - 01/2000
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2009 - 12/2001
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
05/2005 - 06/2001
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
08/2003 - 12/2000
2Lymphoma (Lymphomas)
04/2002 - 06/2001
2Disseminated Intravascular Coagulation
12/2001 - 01/2001
2Graft vs Host Disease (Graft-Versus-Host Disease)
03/2001 - 03/2000
1Weight Loss (Weight Reduction)
01/2017
1Fever (Fevers)
01/2017
1Venous Thromboembolism
10/2016
1Disease Progression
01/2016
1Abnormal Karyotype
09/2013
1Anemia
02/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2011
1POEMS Syndrome (Syndrome, POEMS)
12/2007
1Paraproteinemias (Monoclonal Gammopathy)
12/2007
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
09/2006
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2006
1Thromboembolism
05/2005
1Multiple Myeloma
03/2003
1Infertility (Sterility)
07/2002
1Breast Neoplasms (Breast Cancer)
05/2002
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2001
1Infections
12/2001
1Prolymphocytic Leukemia
12/2001
1T-Cell Lymphoma (Lymphoma, T Cell)
08/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2001
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2001

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
01/2015 - 03/2000
4ruxolitinibIBA
01/2017 - 02/2011
4Hydroxyurea (Hydrea)FDA LinkGeneric
02/2007 - 01/2000
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2012 - 01/2000
3Rituximab (Mabthera)FDA Link
03/2009 - 06/2001
3Hemostatics (Antihemorrhagics)IBA
05/2002 - 01/2001
2Janus Kinase InhibitorsIBA
01/2016 - 02/2011
2Janus KinasesIBA
01/2016 - 02/2011
2defibrotideIBA
08/2003 - 12/2000
2Etoposide (VP 16)FDA LinkGeneric
07/2002 - 08/2001
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2002 - 08/2001
2Prednisolone (Predate)FDA LinkGeneric
07/2002 - 03/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2002 - 08/2000
2Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2002 - 12/2001
2AntibodiesIBA
06/2001 - 12/2000
2Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2001 - 03/2000
2Busulfan (Busulfex)FDA Link
03/2001 - 09/2000
2AnthracyclinesIBA
01/2001 - 01/2000
1Phosphotransferases (Kinase)IBA
01/2017
1Vitamin KFDA Link
10/2016
1Hemoglobins (Hemoglobin)IBA
10/2014
1C-Reactive ProteinIBA
10/2013
1Dihydrotachysterol (AT 10)IBA
09/2013
1fedratinibIBA
02/2011
1N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
02/2011
1Imatinib Mesylate (Gleevec)FDA Link
02/2011
1Biological FactorsIBA
08/2008
1Histone Deacetylase InhibitorsIBA
04/2008
1givinostat hydrochlorideIBA
04/2008
1Anaplastic Lymphoma KinaseIBA
09/2006
1Warfarin (Coumadin)FDA LinkGeneric
05/2005
1PolydeoxyribonucleotidesIBA
08/2003
1Thalidomide (Thalomid)FDA Link
03/2003
1Bleomycin (Blenoxane)FDA LinkGeneric
07/2002
1Prednisone (Sone)FDA LinkGeneric
07/2002
1Procarbazine (Matulane)FDA Link
07/2002
1Vinblastine (Vinblastine Sulfate)FDA Link
07/2002
14-O-carboxymethylascochlorinIBA
07/2002
1Chlorambucil (Leukeran)FDA Link
07/2002
1Vincristine (Oncovin)FDA LinkGeneric
07/2002
1Plasminogen Activator Inhibitor 1IBA
05/2002
1TamoxifenFDA LinkGeneric
05/2002
1Dacarbazine (DIC)FDA LinkGeneric
12/2001
1Complement System Proteins (Complement)IBA
12/2001
1Methotrexate (Mexate)FDA LinkGeneric
08/2001
1Monoclonal AntibodiesIBA
06/2001
1Phospholipids (Phosphatides)FDA LinkGeneric
06/2001
1Urea (Carbamide)FDA LinkGeneric
03/2001
1Immunoglobulin G (IgG)IBA
12/2000
1AnticoagulantsIBA
12/2000

Therapy/Procedure

14Therapeutics
01/2017 - 01/2000
8Drug Therapy (Chemotherapy)
03/2009 - 09/2000
6Stem Cell Transplantation
11/2015 - 11/2000
2Autologous Transplantation
03/2009 - 08/2001
2Radiotherapy
08/2003 - 06/2001
2Remission Induction
08/2000 - 01/2000
1Duration of Therapy
10/2016
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2007
1Salvage Therapy
08/2001
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2001